切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (05) : 360 -363. doi: 10.3877/cma.j.issn.1674-3253.2020.05.010

临床研究

膀胱内前列腺突出度在基层医院前列腺切除术中的应用
张军1,(), 魏春燕1, 黄万鹏1, 刘若旦1   
  1. 1. 517300 广东,龙川县中医院泌尿外科
  • 收稿日期:2019-08-17 出版日期:2020-10-10
  • 通信作者: 张军

The clinical value of intravesical prostatic protrusion in transurethral resection prostate in primary hospitals

Jun Zhang1,(), Chunyan Wei1, Wanpeng Huang1, Ruodan Liu1   

  1. 1. Department of Urology, Longchuan County Hospital of Traditional Chinese Medicine, Guangdong 517300, China
  • Received:2019-08-17 Published:2020-10-10
  • Corresponding author: Jun Zhang
引用本文:

张军, 魏春燕, 黄万鹏, 刘若旦. 膀胱内前列腺突出度在基层医院前列腺切除术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(05): 360-363.

Jun Zhang, Chunyan Wei, Wanpeng Huang, Ruodan Liu. The clinical value of intravesical prostatic protrusion in transurethral resection prostate in primary hospitals[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2020, 14(05): 360-363.

目的

探讨膀胱内前列腺突出度(IPP)在基层医院前列腺切除术中的临床应用价值。

方法

回顾性分析广东省龙川县中医院泌尿外科2016年3月至2019年3月收治的105例前列腺增生并行经尿道前列腺等离子电切术(TURP)患者的临床资料,分为IPP<5 mm组及IPP≥5 mm组,比较两组患者术前与术后最大尿流率(Qmax)、残余尿量(RUV)、国际前列腺症状评分(IPSS)指标的差异。

结果

IPP≥5 mm组患者术前平均Qmax较IPP<5 mm组低,差异有统计学意义;IPP≥5 mm组患者术前平均IPSS评分及平均RUV均较IPP<5 mm组高,差异均有统计学意义;两组患者术后3个月的IPSS评分以及RUV、Qmax指标差异均无统计学意义,但是IPP≥5 mm组患者,术后Qmax提升幅度、RUV减少量、IPSS评分下降范围更为明显,差异有统计学意义。

结论

BPH患者的临床症状、RUV与IPP长度呈正相关,Qmax则与IPP长度呈负相关,IPP≥5 mm的BPH患者手术疗效更显著。IPP操作简便且廉价,患者接受程度高,适宜基层医院推广。

Objective

To explore the clinical value of intravesical prostatic protrusion (IPP) in primary hospitals.

Methods

A total of 105 patients of benign prostatic hyperplasia (BPH) underwent transurethral resection prostate (TURP) in Longchuan County Hospital of Traditional Chinese Medicine from Mar. 2016 to Mar. 2019. The patients were classified into group IPP<5 mm and group IPP≥5 mm, the differences of the maximal urinary flow (Qmax) and residual urine volume (RUV) and index of international prostate symptom score (IPSS) in two groups were analyzed comparatively.

Results

The average Qmax of patients in IPP≥5 mm group was lower than that in IPP<5 mm group, the difference was statistically significant. The average IPSS and average RUV of patients in IPP≥5 mm group were higher than those in IPP <5 mm group, the difference were statistically significant. There was no significant difference in IPSS, RUV and Qmax between the two groups at 3 months after operation. However, in the group of IPP≥5 mm, the Qmax increased, the residual urine volume decreased, and the IPSS score decreased more significantly, the difference were statistically significant.

Concusion

The clinical symptoms and RUV of BPH were positively correlated with the length of IPP, while the Qmax was negatively correlated with the length of IPP. The curative effect of BPH patients with IPP≥5 mm was more significant. IPP is simple and cheap, and the patient has a high degree of acceptance which is suitable for promotion in primary hospitals.

表1 术前IPP<5 mm组和IPP≥5 mm组各指标的比较(±s
表2 术后3个月IPP<5 mm组和IPP≥5 mm组各指标的比较(±s
表3 两组术后3个月与术前各指标变化值的比较(±s
[1]
卢智泉,聂绍发. 良性前列腺增生的流行病学研究现状[J].国际泌尿系统杂志, 2007, 27(3): 351.
[2]
刘俊峰,谭朝晖,李三祥, 等. 经尿道双极等离子前列腺剜除术与经尿道双极等离子电切术比较治疗前列腺增生的临床研究[J]. 中国循证医学杂志, 2013, 13(12): 1405-1408.
[3]
Hirayama K, Masui K, Hamada A, et al. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention[J]. J Urol, 2015, 86(3): 565-569.
[4]
那彦群,叶章群,孙光, 等.中国泌尿外科疾病诊断治疗指南[M](2014版),人民卫生出版社,北京, 2013.
[5]
Keqin Z, Zhishun X, Jing Z, et al. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement[J]. J Urol, 2007, 70(6): 1096-1099.
[6]
Zheng J, Pan J, Qin Y, et al. Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluidstructural interaction analysis study [J] .BMC Urol, 2015,15:86.
[7]
黄维,刘励,陈光勇, 等. 前列腺突入膀胱距离及逼尿肌厚度与膀胱出口梗阻的关系探讨[J]. 东南国防医药, 2012, 14(5): 435-437.
[8]
Lee LS, Sim HG, Lim KB, et al. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment[J]. Int J Urol2010, 17(1):69-74.
[9]
张浩,司徒杰,张炎,等.膀胱内前列腺突出程度可作为良性前列腺增生临床进展的高危因素[J/CD].中华腔镜泌尿外科杂志(电子版),2012,6(4):292-295.
[10]
许常杰,曹曙,蒋思雄, 等. 前列腺突入膀胱程度与最大尿流率的关系研究[J]. 大连医科大学学报, 2013, 35(5): 464-467.
[11]
郭雪涛,李从刚,刘和. 良性前列腺增生突入膀胱程度与尿流动力学的临床意义[J]. 现代泌尿外科杂志, 2015, 20(10): 712-714.
[1] 李辉, 尉维录, 吴茂林. 经直肠剪切波弹性成像对存在下尿路症状的前列腺病变良恶性的鉴别诊断价值及其影响因素分析[J/OL]. 中华医学超声杂志(电子版), 2023, 20(11): 1193-1198.
[2] 程志刚, 魏辉, 李一波, 韩健, 钟永豪, 王铭, 张文辉, 周传东. 经尿道前列腺剜除术中保留前列腺分叶沟间组织对术后顺行射精功能的保护[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 453-458.
[3] 李想, 郭征, 田洪哲, 李杜, 熊梦瑶, 潘铁军. 1 470 nm半导体激光减容性切除治疗高危前列腺增生的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 448-452.
[4] 莫林键, 杨舒博, 农卫赟, 程继文. 人工智能虚拟数字医师在钬激光前列腺剜除日间手术患教管理中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 318-322.
[5] 杨登科, 蔡明志, 张星星, 胡青, 郭大勇, 高喆, 毕永启, 胡伟. 腹腔镜膀胱颈Y-V成形术与经尿道膀胱颈电切治疗膀胱颈挛缩的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 392-396.
[6] 潘兴赫, 董翔, 杨海洋, 张雪斌, 甘卫东. 超选择性前列腺动脉栓塞治疗伴急性尿潴留的高危高龄前列腺增生[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 237-242.
[7] 曾明辉, 蒋东方, 秦锁炳. 钬激光前列腺剜除术治疗前列腺增生疗效的影响因素[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 157-161.
[8] 汪洋, 李志鹏, 张楠, 何海填, 杨伟锋, 张焕灵, 王可兵. 保护射精技术在前列腺等离子剜除术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 152-156.
[9] 张铭星, 刘文倩, 王以然, 赵泽恬, 袁欣怡, 丁留成. 江苏地区腹腔镜下前列腺癌根治术后一年夜尿症发生率及相关危险因素多中心回顾性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 141-145.
[10] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[11] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[12] 梅鑫, 张世科, 张巧珍, 吴文起. 前列腺增生导致下尿路症状手术时机的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 96-99.
[13] 李腾成, 黄群雄, 胡成, 肖恒军, 徐锦斌, 高舜天, 黄展森, 高新, 狄金明. 机器人腹腔镜后入路筋膜内和筋膜外根治性前列腺切除术技术分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 12-18.
[14] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[15] 郑军, 许新, 江爽, 俞继卫. 经腹腹膜前疝修补术治疗前列腺根治性切除术后并发腹股沟疝疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 557-560.
阅读次数
全文


摘要